Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...
"She's just wired a different way," Stanford told MedPage Today, noting part of the consideration for using new GLP-1 ...
It broke open a market that could reach $130 billion by 2030 and has a cultural reach broader than any new drug since Viagra. Yet to keep its lead in the red-hot field of obesity, Novo must ...
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...
The prevalence of obesity and overweight is extraordinarily high. Unsurprisingly, deaths related to obesity are on the rise, ...
Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...